These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
252 related items for PubMed ID: 2206537
21. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5. Yamaguchi T, Kimura H, Kurabayashi M, Kozawa K, Kato M. Immunol Lett; 2008 Jun 15; 118(1):88-95. PubMed ID: 18440651 [Abstract] [Full Text] [Related]
22. Human granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulates immature marrow precursors but no CFU-GM, CFU-G, or CFU-M. Bot FJ, van Eijk L, Schipper P, Löwenberg B. Exp Hematol; 1989 Mar 15; 17(3):292-5. PubMed ID: 2645158 [Abstract] [Full Text] [Related]
23. Pleural fluid levels of interleukin-5 and eosinophils are closely correlated. Mohamed KH, Abdelhamid AI, Lee YC, Lane KB, Conner B, Hawthorne M, Light RW. Chest; 2002 Aug 15; 122(2):576-80. PubMed ID: 12171834 [Abstract] [Full Text] [Related]
25. Induction of CD23, CD25 and CD4 expression on an eosinophilic cell line (EoL-3) by interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-5 (IL-5). Chihara J, Gruart V, Plumas J, Tavernier J, Kusnierz JP, Prin L, Capron A, Capron M. Eur Cytokine Netw; 1992 Aug 15; 3(1):53-61. PubMed ID: 1533800 [Abstract] [Full Text] [Related]
26. Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte-macrophage colony-stimulating factor. Levi-Schaffer F, Temkin V, Malamud V, Feld S, Zilberman Y. J Immunol; 1998 Jun 01; 160(11):5554-62. PubMed ID: 9605160 [Abstract] [Full Text] [Related]
27. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation. Ohkawara Y, Lei XF, Stämpfli MR, Marshall JS, Xing Z, Jordana M. Am J Respir Cell Mol Biol; 1997 May 01; 16(5):510-20. PubMed ID: 9160833 [Abstract] [Full Text] [Related]
28. In vivo production of interleukin-5, granulocyte-macrophage colony-stimulating factor, macrophages colony-stimulating factor, and interleukin-6 during intravenous administration of high-dose interleukin-2 in cancer patients. Schaafsma MR, Falkenburg JH, Landegent JE, Duinkerken N, Osanto S, Ralph P, Kaushansky K, Wagemaker G, Van Damme J, Willemze R. Blood; 1991 Oct 15; 78(8):1981-7. PubMed ID: 1912580 [Abstract] [Full Text] [Related]
29. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Tai PC, Sun L, Spry CJ. Clin Exp Immunol; 1991 Aug 15; 85(2):312-6. PubMed ID: 1864012 [Abstract] [Full Text] [Related]
30. [The assessment of Eo-CSF and cytokines as eosinopoietic factor]. Kamei T. Nihon Rinsho; 1993 Mar 15; 51(3):736-40. PubMed ID: 8492450 [Abstract] [Full Text] [Related]
31. Potentiating effect of granulocyte-macrophage colony-stimulating factor on interleukin-1-induced thymocyte proliferation: evidence for an interleukin-2 and tumor necrosis factor-independent pathway. Herbelin A, Machavoine F, Dy M. Lymphokine Res; 1990 Mar 15; 9(2):155-65. PubMed ID: 2187117 [Abstract] [Full Text] [Related]
32. In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5. Rivoltini L, Viggiano V, Spinazzè S, Santoro A, Colombo MP, Takatsu K, Parmiani G. Int J Cancer; 1993 Apr 22; 54(1):8-15. PubMed ID: 8386711 [Abstract] [Full Text] [Related]
34. Production of granulocyte colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor after interleukin-1 stimulation of marrow stromal cell cultures from normal or aplastic anemia donors. Migliaccio AR, Migliaccio G, Adamson JW, Torok-Storb B. J Cell Physiol; 1992 Jul 22; 152(1):199-206. PubMed ID: 1377699 [Abstract] [Full Text] [Related]
35. Secretion of the eosinophil-active cytokines interleukin-5, granulocyte/macrophage colony-stimulating factor and interleukin-3 by bronchoalveolar lavage CD4+ and CD8+ T cell lines in atopic asthmatics, and atopic and non-atopic controls. Till S, Li B, Durham S, Humbert M, Assoufi B, Huston D, Dickason R, Jeannin P, Kay AB, Corrigan C. Eur J Immunol; 1995 Oct 22; 25(10):2727-31. PubMed ID: 7589063 [Abstract] [Full Text] [Related]
36. Comparison of effects of anti-IL-3, IL-5 and GM-CSF treatments on eosinophilopoiesis and airway eosinophilia induced by allergen. Tomaki M, Zhao LL, Sjöstrand M, Lindén A, Ichinose M, Lötvall J. Pulm Pharmacol Ther; 2002 Oct 22; 15(2):161-8. PubMed ID: 12090790 [Abstract] [Full Text] [Related]